The EACPT Executive Committee was meeting in Vienna from 10th – 11th November to plan for future activities. Key matters for discussion include 1. Future EACPT Congresses – the next is due to be held in 2019 in Stockholm as a partnership between the EACPT and the Swedish Society for Pharmacology, Clinical Pharmacology and Therapeutics. … Read more
The EACPT 2017 Congress was held in Prague from 24th-27th June with 566 participants from all 5 continents – 28% from beyond the European Region, from Australia to China, Japan and South Korea to the USA. The Congress included 22 sessions with Keynote Lectures on current issues for research, education and clinical practice on safe … Read more
Publication: Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2). Journal: Lancet 105; 386(10008): 2059–68.
The EACPT is delighted to announce that the 2017 Lifetime Achievement Award of the European Association of Clinical Pharmacology and Therapeutics will go to Professor Pertti Neuvonen from Finland.
Reduction of adverse effects from intravenous acetylcysteine treatment for paracetamol poisoning. Lancet 2014; 383(9918): 697–704.
The EACPT is delighted to announce that the 2015 Lifetime Achievement Award of the European Association of Clinical Pharmacology and Therapeutics will go to Prof. Michel Eichelbaum from Germany.
Publication: Methylphenidate for gait hypokinesia and freezing in patients with Parkinson’s disease undergoing subthalamic stimulation. Journal: Lancet Neurology 2012; 11(7): 589–596
The EACPT is delighted to announce that the 2013 Lifetime Achievement Award of the European Association of Clinical Pharmacology and Therapeutics will go to Sir Michael Rawlins MD, PhD. from the United Kingdom.
The EACPT is delighted to announce that the 2013 Lifetime Achievement Award of the European Association of Clinical Pharmacology and Therapeutics will go to Prof. Carlo Patrono from Italy.
Publication: Genetic determinants of response to clopidogrel and cardiovascular events. Journal: New England Journal of Medicine.